Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08DWM
|
||||
| Former ID |
DIB000597
|
||||
| Drug Name |
Gp100:209-217(210M) peptide vaccine
|
||||
| Synonyms |
Gp100 melanoma-associated antigen vaccine, NCI; Gp100:209-217(210M) peptide vaccine (melanoma); Gp100:209-217(210M) peptide vaccine (melanoma), NCI
|
||||
| Drug Type |
Vaccine
|
||||
| Indication | Melanoma [ICD9: 172; ICD10:C43] | Phase 2 | [521456] | ||
| Company |
National Cancer Institute
|
||||
| Target and Pathway | |||||
| Target(s) | Melanocytes lineage-specific antigen GP100 | Target Info | [550405] | ||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.